aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Athos Therapeutics, founded to revolutionize treatment for autoimmune diseases and cancer, is a late pre-clinical stage biotechnology company. Their core mission is to develop AI-based precision therapeutics tailored for patients with inflammatory bowel disease, other autoimmune conditions, and cancer. By leveraging advanced artificial intelligence, Athos aims to create more effective and personalized treatment options, addressing significant unmet medical needs in these areas.
Notable figures associated with Athos Therapeutics include its founders and a distinguished Scientific Advisory Board comprising experts in biotechnology and medicine. The company has garnered attention for its innovative approach and has made significant strides in pre-clinical development. Athos's impact lies in its potential to transform patient care through precision medicine, promising more targeted and effective treatments for complex diseases.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Therapeutics
Technology
AI, Machine Learning
Tags
Biotech, Ai Operations
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Athos Therapeutics founded?
Athos Therapeutics was founded in 2019.
Where is Athos Therapeutics's headquarters located?
Athos Therapeutics's headquarters is located in Los Angeles, CA, US.
When was Athos Therapeutics's last funding round?
Athos Therapeutics's most recent funding round was for $15M (USD) in November 2021.
How many employees does Athos Therapeutics have?
Athos Therapeutics has 15 employees as of Feb 5, 2024.
How much has Athos Therapeutics raised to-date?
As of July 05, 2023, Athos Therapeutics has raised a total of $19.3M (USD) since Nov 15, 2021.
Add Comparison
Total Raised to Date
$19.3M
USD
Last Update Nov 15, 2021
Last Deal Details
$15M
USD
Nov 15, 2021
Series A
Total Employees Over Time
15
As of Feb 2024
Athos Therapeutics Address
11301 Olympic Boulevard
suite 592
Los Angeles,
California
90064
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts